Chicago Capital, LLC Dynavax Technologies Corp Transaction History

Chicago Capital, LLC

$3.56 Billion
Q3 2024

A detailed history of Chicago Capital, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Chicago Capital, LLC holds 5,489,896 shares of DVAX stock, worth $70.5 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares

5,489,896

Previous 5,602,073 2.0%

Holding current value

$70.5 Million

Previous $62.9 Million 2.79%

% of portfolio

1.72%

Previous 1.89%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$10.05 - $11.61 $1.13 Million - $1.3 Million	-112,177 Reduced 2.0%	5,489,896 $61.2 Million
Q2 2024 Aug 06, 2024	SELL	$10.73 - $12.58 $432,805 - $507,426	-40,336 Reduced 0.71%	5,602,073 $62.9 Million
Q1 2024 Apr 15, 2024	SELL	$11.7 - $14.98 $595,764 - $762,781	-50,920 Reduced 0.89%	5,642,409 $70 Million
Q4 2023 Jan 22, 2024	SELL	$13.09 - $14.98 $1.29 Million - $1.47 Million	-98,406 Reduced 1.7%	5,693,329 $79.6 Million
Q3 2023 Oct 25, 2023	SELL	$12.64 - $14.99 $236,785 - $280,807	-18,733 Reduced 0.32%	5,791,735 $85.5 Million
Q2 2023 Jul 20, 2023	SELL	$9.85 - $13.17 $342,583 - $458,052	-34,780 Reduced 0.6%	5,810,468 $75.1 Million
Q1 2023 Apr 18, 2023	SELL	$9.44 - $11.88 $95,230 - $119,845	-10,088 Reduced 0.17%	5,845,248 $57.3 Million
Q4 2022 Jan 20, 2023	BUY	$10.27 - $13.29 $467,346 - $604,774	45,506 Added 0.78%	5,855,336 $0
Q3 2022 Oct 14, 2022	SELL	$9.93 - $17.44 $328,444 - $576,845	-33,076 Reduced 0.57%	5,809,830 $60.7 Million
Q2 2022 Jul 21, 2022	SELL	$7.45 - $12.83 $95,404 - $164,300	-12,806 Reduced 0.22%	5,842,906 $73.6 Million
Q1 2022 Apr 21, 2022	BUY	$9.75 - $14.44 $1.19 Million - $1.76 Million	121,678 Added 2.12%	5,855,712 $63.5 Million
Q4 2021 Jan 20, 2022	BUY	$13.17 - $20.94 $174,871 - $278,041	13,278 Added 0.23%	5,734,034 $80.7 Million
Q3 2021 Oct 28, 2021	SELL	$9.16 - $19.83 $1.45 Million - $3.14 Million	-158,203 Reduced 2.69%	5,720,756 $110 Million
Q2 2021 Jul 22, 2021	BUY	$7.25 - $10.99 $645,960 - $979,187	89,098 Added 1.54%	5,878,959 $57.9 Million
Q1 2021 Apr 13, 2021	BUY	$4.57 - $11.18 $33,137 - $81,066	7,251 Added 0.13%	5,789,861 $56.9 Million
Q4 2020 Jan 25, 2021	BUY	$3.73 - $5.6 $6.91 Million - $10.4 Million	1,852,086 Added 47.12%	5,782,610 $25.7 Million
Q3 2020 Oct 13, 2020	SELL	$4.32 - $11.7 $4.21 Million - $11.4 Million	-974,171 Reduced 19.86%	3,930,524 $17 Million
Q2 2020 Jul 29, 2020	BUY	$2.94 - $9.1 $2.03 Million - $6.27 Million	689,170 Added 16.35%	4,904,695 $43.5 Million
Q1 2020 Apr 21, 2020	BUY	$2.27 - $6.2 $489,831 - $1.34 Million	215,785 Added 5.39%	4,215,525 $14.9 Million
Q4 2019 Jan 14, 2020	SELL	$3.46 - $6.93 $1.32 Million - $2.64 Million	-380,476 Reduced 8.69%	3,999,740 $22.9 Million
Q3 2019 Oct 29, 2019	BUY	$2.69 - $4.85 $3.88 Million - $7 Million	1,442,950 Added 49.13%	4,380,216 $15.7 Million
Q2 2019 Jul 11, 2019	BUY	$3.65 - $7.89 $1.43 Million - $3.1 Million	393,124 Added 15.45%	2,937,266 $11.7 Million
Q1 2019 Apr 23, 2019	BUY	$7.08 - $12.09 $2.85 Million - $4.87 Million	402,411 Added 18.79%	2,544,142 $18.6 Million
Q4 2018 Feb 11, 2019	SELL	$8.14 - $13.28 $897,964 - $1.46 Million	-110,315 Reduced 4.9%	2,141,731 $19.6 Million
Q3 2018 Nov 02, 2018	BUY	$11.85 - $16.0 $11.4 Million - $15.3 Million	957,942 Added 74.02%	2,252,046 $27.9 Million
Q2 2018 Jul 19, 2018	BUY	$15.15 - $20.75 $6.38 Million - $8.75 Million	421,446 Added 48.29%	1,294,104 $19.7 Million
Q1 2018 May 09, 2018	BUY	$14.65 - $19.9 $12.8 Million - $17.4 Million	872,658 New	872,658 $17.3 Million

Others Institutions Holding DVAX

# of Institutions

275

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.62B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.

Account

Chicago Capital, LLC Dynavax Technologies Corp Transaction History